Minneapolis, MN, United States of America

Kirk D Shoger

This inventor holds 10 USPTO granted patents. Top assignees: Hoechst Roussel Pharmaceuticals, Hoeschst-Roussel Incorporated, Other. Active years: 1988-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kirk D Shoger. Retrieved from https://idiyas.com/inventor/kirk-d-shoger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 8(Granted Patents)

Location History:

Piscataway, NJ (US) (1988 - 1991)
Minneapolis, MN (US) (1991 - 1992)

Company Filing History:

8 out of 539

Hoechst Roussel Pharmaceuticals

patents

1 out of 1

Hoeschst-Roussel Incorporated

patent

1 out of 834,513

Other

patents

Years Active: 1988-1992

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5145844 - Methods of using hydroxy-, alkoxy- and benzyloxy-substituted (1992-09-08),

2. 5045539 - 1H-indolo[3,2-c]quinoline-derivatives, compositions containing same, (1991-09-03),

3. 5036152 - Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids (1991-07-30),

4. 5030733 - Hydroxy-, alkoxy- and benzyloxy-substituted phospholipids (1991-07-09),

5. 5006531 - 5,6-dihydro(1H-indolo(3,2-C)quinoline-6,4'-piperidines) and related (1991-04-09),

6. 4985450 - Arylthiadiazolylsulfonamides and derivatives (1991-01-15),

7. 4888328 - Alkoxycarbonylalkylphospholipids and alkylaminocarbonylalkylphospholipids (1989-12-19),

8. 4873239 - Arylthiadiazolylsulfonamides and derivatives (1989-10-10),

9. 4800200 - 4,8-dihydro-8-arylisoxazolo[4,3-e][1,4]-oxazepin-5(6H)-ones (1989-01-24),

10. 4758578 - Arylthiadiazolylsulfonamides, pharmaceutical compositions and use (1988-07-19),

Title: Kirk D. Shoger: Innovator in Pharmaceutical Research

Introduction

Kirk D. Shoger is a notable inventor based in Minneapolis, MN, recognized for his significant contributions to pharmaceutical research. With a prolific career that includes the issuance of 10 patents, Shoger's work primarily focuses on innovative methods and compounds aimed at addressing complex medical conditions.

Latest Patents

Among his latest patents, Shoger has developed methods utilizing hydroxy-, alkoxy-, and benzyloxy-substituted compounds. His work includes the formulation of novel hydroxy-, alkoxy-, and benzyloxy-substituted phospholipids, which are crucial in the treatment of pain, phospholipase A2 mediated inflammation, and other related medical conditions. Additionally, he has introduced 1H-indolo[3,2-c]quinoline-derivatives and compositions that leverage these compounds for therapeutic applications.

Career Highlights

Throughout his career, Kirk D. Shoger has worked at several reputable companies, including Hoechst Roussel Pharmaceuticals, where he honed his skills in drug development and innovation. His extensive knowledge and experience in the field have made him a vital asset in advancing pharmaceutical technologies.

Collaborations

Shoger has collaborated with esteemed professionals in the field, including John J. Tegeler and Grover C. Helsley. These partnerships have contributed to the successful development of his patented inventions, enhancing the impact of his research on pharmaceutical solutions.

Conclusion

Kirk D. Shoger stands out as a prolific inventor with a strong influence in the pharmaceutical industry. His innovative patents and collaborative efforts have the potential to transform treatments for pain and inflammation, showcasing the importance of creativity and expertise in medical research.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]